FDA Cloak And Dagger: GMP "Intelligence" Sought As Part Of Globalization Plan
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency wants to target supply-chain threats and help judge the value of information received from third-party inspections.
You may also be interested in...
Drug Shortage Rules Surface In Latest FDA Regulatory Agenda
FDA has yet to prognosticate on a schedule for other FDASIA-mandated regulations; HHS says that FDA’s priorities for the coming year will involve devices and food, as well as promoting international regulatory cooperation.
IOM Pushes For FDA Collaboration With Foreign Regulators
In a report on how FDA, industry and other stakeholders can strengthen food and drug regulatory systems abroad, the Institute of Medicine recommends the agency provide incentives for foreign regulators to meet U.S. standards and facilitate training and for the government to help hold importers liable.
IOM Pushes For FDA Collaboration With Foreign Regulators
In a report on how FDA, industry and other stakeholders can strengthen food and drug regulatory systems abroad, the Institute of Medicine recommends the agency provide incentives for foreign regulators to meet U.S. standards and facilitate training and for the government to help hold importers liable.